{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:21:00Z","timestamp":1790198460231,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-025-02160-y","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:18:39Z","timestamp":1773746319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["IL-22\/IL-22R signaling attenuates mitochondrial damage in PCOS by modulating granulosa cell lipid metabolism through ETS1"],"prefix":"10.1007","volume":"75","author":[{"given":"Man","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"1","key":"2160_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","volume":"10","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin E, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2024;10(1):27.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"2160_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s13668-023-00479-8","volume":"12","author":"M Di Lorenzo","year":"2023","unstructured":"Di Lorenzo M, et al. Pathophysiology and nutritional approaches in polycystic ovary syndrome (PCOS): A comprehensive review. Curr Nutr Rep. 2023;12(3):527\u201344.","journal-title":"Curr Nutr Rep"},{"issue":"1","key":"2160_CR3","doi-asserted-by":"publisher","first-page":"e20241056","DOI":"10.1590\/1806-9282.20241056","volume":"71","author":"E Ta\u015fkin","year":"2025","unstructured":"Ta\u015fkin E, Ero\u011flu S. Investigation of associations between polycystic ovary syndrome and INSR gene polymorphisms rs2059806 and rs2252673. Rev Assoc Med Bras (1992). 2025;71(1):e20241056.","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"1","key":"2160_CR4","doi-asserted-by":"publisher","first-page":"2357737","DOI":"10.1080\/07853890.2024.2357737","volume":"56","author":"NA Sta\u0144czak","year":"2024","unstructured":"Sta\u0144czak NA, Grywalska E, Dudzi\u0144ska E. The latest reports and treatment methods on polycystic ovary syndrome. Ann Med. 2024;56(1):2357737.","journal-title":"Ann Med"},{"key":"2160_CR5","doi-asserted-by":"crossref","unstructured":"Tsai YR, Liao YN, Kang HY. Current advances in cellular approaches for pathophysiology and treatment of polycystic ovary syndrome. Cells. 2023;12(17):2189.","DOI":"10.3390\/cells12172189"},{"key":"2160_CR6","doi-asserted-by":"crossref","unstructured":"Siemers KM, Klein AK, Baack ML. Mitochondrial dysfunction in PCOS: insights into reproductive organ pathophysiology. Int J Mol Sci. 2023;24(17):13123.","DOI":"10.3390\/ijms241713123"},{"key":"2160_CR7","doi-asserted-by":"publisher","first-page":"1193749","DOI":"10.3389\/fmed.2023.1193749","volume":"10","author":"Y Gao","year":"2023","unstructured":"Gao Y, et al. Oxidative stress and mitochondrial dysfunction of granulosa cells in polycystic ovarian syndrome. Front Med (Lausanne). 2023;10:1193749.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"2160_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12020-011-9495-9","volume":"40","author":"W Hu","year":"2011","unstructured":"Hu W, Qiao J. Expression and regulation of adipocyte fatty acid binding protein in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome. Endocrine. 2011;40(2):196\u2013202.","journal-title":"Endocrine"},{"key":"2160_CR9","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3389\/fphys.2020.00600","volume":"11","author":"X Chen","year":"2020","unstructured":"Chen X, et al. FASN-Mediated lipid metabolism regulates Goose granulosa cells apoptosis and steroidogenesis. Front Physiol. 2020;11:600.","journal-title":"Front Physiol"},{"issue":"1","key":"2160_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12958-024-01337-0","volume":"22","author":"H Yan","year":"2024","unstructured":"Yan H, et al. Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: from mechanisms to therapeutic strategies. Reprod Biol Endocrinol. 2024;22(1):159.","journal-title":"Reprod Biol Endocrinol"},{"key":"2160_CR11","doi-asserted-by":"publisher","first-page":"1470283","DOI":"10.3389\/fimmu.2024.1470283","volume":"15","author":"H Deng","year":"2024","unstructured":"Deng H, et al. Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome. Front Immunol. 2024;15:1470283.","journal-title":"Front Immunol"},{"issue":"1","key":"2160_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13048-023-01236-9","volume":"16","author":"Y Geng","year":"2023","unstructured":"Geng Y, et al. Opportunities and challenges: interleukin-22 comprehensively regulates polycystic ovary syndrome from metabolic and immune aspects. J Ovarian Res. 2023;16(1):149.","journal-title":"J Ovarian Res"},{"issue":"1","key":"2160_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00281-009-0188-x","volume":"32","author":"K Wolk","year":"2010","unstructured":"Wolk K, et al. Biology of interleukin-22. Semin Immunopathol. 2010;32(1):17\u201331.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"2160_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s10020-021-00353-9","volume":"27","author":"JW Luo","year":"2021","unstructured":"Luo JW, et al. Interleukin-22: a potential therapeutic target in atherosclerosis. Mol Med. 2021;27(1):88.","journal-title":"Mol Med"},{"issue":"1","key":"2160_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.alit.2018.10.002","volume":"68","author":"T Ito","year":"2019","unstructured":"Ito T, Hirose K, Nakajima H. Bidirectional roles of IL-22 in the pathogenesis of allergic airway inflammation. Allergol Int. 2019;68(1):4\u20138.","journal-title":"Allergol Int"},{"issue":"4","key":"2160_CR16","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","volume":"50","author":"W Ouyang","year":"2019","unstructured":"Ouyang W, O\u2019Garra A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 2019;50(4):871\u201391.","journal-title":"Immunity"},{"key":"2160_CR17","doi-asserted-by":"crossref","unstructured":"Sajiir H, et al. Harnessing IL-22 for metabolic health: promise and pitfalls. Trends Mol Med. 2024;31(6):574\u201384.","DOI":"10.1016\/j.molmed.2024.10.016"},{"key":"2160_CR18","doi-asserted-by":"publisher","first-page":"1137089","DOI":"10.3389\/fimmu.2023.1137089","volume":"14","author":"M Luo","year":"2023","unstructured":"Luo M, et al. E. coli Nissle 1917 ameliorates mitochondrial injury of granulosa cells in polycystic ovary syndrome through promoting gut immune factor IL-22 via gut microbiota and microbial metabolism. Front Immunol. 2023;14:1137089.","journal-title":"Front Immunol"},{"issue":"8","key":"2160_CR19","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","volume":"25","author":"X Qi","year":"2019","unstructured":"Qi X, et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019;25(8):1225\u201333.","journal-title":"Nat Med"},{"key":"2160_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fmicb.2019.00175","volume":"10","author":"F Zhang","year":"2019","unstructured":"Zhang F, et al. Diversity of the gut microbiota in Dihydrotestosterone-Induced PCOS rats and the Pharmacologic effects of Diane-35, Probiotics, and Berberine. Front Microbiol. 2019;10:175.","journal-title":"Front Microbiol"},{"key":"2160_CR21","doi-asserted-by":"crossref","unstructured":"Pieczy\u0144ska JM, et al. The role of a High-Fat, High-Fructose diet on Letrozole-Induced polycystic ovarian syndrome in prepubertal mice. Nutrients. 2022;14(12):2478.","DOI":"10.3390\/nu14122478"},{"issue":"2","key":"2160_CR22","doi-asserted-by":"publisher","first-page":"e13291","DOI":"10.1111\/acel.13291","volume":"20","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, et al. \u03b1-ketoglutarate delays age-related fertility decline in mammals. Aging Cell. 2021;20(2):e13291.","journal-title":"Aging Cell"},{"key":"2160_CR23","doi-asserted-by":"publisher","first-page":"789008","DOI":"10.3389\/fendo.2022.789008","volume":"13","author":"L Song","year":"2022","unstructured":"Song L, et al. Androgen excess induced mitochondrial abnormality in ovarian granulosa cells in a rat model of polycystic ovary syndrome. Front Endocrinol (Lausanne). 2022;13:789008.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2160_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12964-022-00876-6","volume":"20","author":"J Cao","year":"2022","unstructured":"Cao J, et al. Follicular fluid-derived Exosomal miR-143-3p\/miR-155-5p regulate follicular dysplasia by modulating Glycolysis in granulosa cells in polycystic ovary syndrome. Cell Commun Signal. 2022;20(1):61.","journal-title":"Cell Commun Signal"},{"key":"2160_CR25","doi-asserted-by":"crossref","unstructured":"Zhu L, et al. System analysis based on Lipid-Metabolism-Related genes identifies AGT as a novel therapy target for gastric cancer with neoadjuvant chemotherapy. Pharmaceutics. 2023;15(3):810.","DOI":"10.3390\/pharmaceutics15030810"},{"key":"2160_CR26","doi-asserted-by":"crossref","unstructured":"Ding H, et al. FTO alleviates CdCl(2)-Induced apoptosis and oxidative stress via the AKT\/Nrf2 pathway in bovine granulosa cells. Int J Mol Sci. 2022;23(9):4948.","DOI":"10.3390\/ijms23094948"},{"issue":"1","key":"2160_CR27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12951-023-02182-w","volume":"21","author":"S Yan","year":"2023","unstructured":"Yan S, et al. Nanocomposites based on nanoceria regulate the immune microenvironment for the treatment of polycystic ovary syndrome. J Nanobiotechnol. 2023;21(1):412.","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"2160_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270\u201384.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2160_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467\u2013520.","journal-title":"Endocr Rev"},{"key":"2160_CR30","doi-asserted-by":"publisher","first-page":"815968","DOI":"10.3389\/fendo.2022.815968","volume":"13","author":"B Liao","year":"2022","unstructured":"Liao B, et al. Effects of androgen Excess-Related metabolic disturbances on granulosa cell function and follicular development. Front Endocrinol (Lausanne). 2022;13:815968.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2160_CR31","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jhep.2010.03.004","volume":"53","author":"L Yang","year":"2010","unstructured":"Yang L, et al. Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. J Hepatol. 2010;53(2):339\u201347.","journal-title":"J Hepatol"},{"issue":"1","key":"2160_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.apsb.2020.07.002","volume":"11","author":"Y Shen","year":"2021","unstructured":"Shen Y, et al. VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses. Acta Pharm Sin B. 2021;11(1):127\u201342.","journal-title":"Acta Pharm Sin B"},{"key":"2160_CR33","doi-asserted-by":"publisher","first-page":"915246","DOI":"10.3389\/fimmu.2022.915246","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Yang G. IL22RA1\/JAK\/STAT signaling acts as a cancer target through Pan-Cancer analysis. Front Immunol. 2022;13:915246.","journal-title":"Front Immunol"},{"key":"2160_CR34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.fsi.2022.10.051","volume":"131","author":"X Wang","year":"2022","unstructured":"Wang X, et al. Interleukin (IL)-22 in common carp (Cyprinus Carpio L.): immune modulation, antibacterial defense, and activation of the JAK-STAT signaling pathway. Fish Shellfish Immunol. 2022;131:796\u2013808.","journal-title":"Fish Shellfish Immunol"},{"key":"2160_CR35","doi-asserted-by":"publisher","first-page":"p6621296","DOI":"10.1155\/2021\/6621296","volume":"2021","author":"Y Dong","year":"2021","unstructured":"Dong Y, et al. Interleukin-22 plays a protective role by regulating the JAK2-STAT3 pathway to improve Inflammation, oxidative Stress, and neuronal apoptosis following cerebral Ischemia-Reperfusion injury. Mediators Inflamm. 2021;2021:p6621296.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"2160_CR36","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12967-024-05167-x","volume":"22","author":"Y Qian","year":"2024","unstructured":"Qian Y, et al. Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome. J Transl Med. 2024;22(1):364.","journal-title":"J Transl Med"},{"issue":"1","key":"2160_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00018-025-05609-9","volume":"82","author":"W Chen","year":"2025","unstructured":"Chen W, et al. Melatonin refines ovarian mitochondrial dysfunction in PCOS by regulating the circadian rhythm gene clock. Cell Mol Life Sci. 2025;82(1):104.","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"2160_CR38","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.cmet.2024.06.010","volume":"36","author":"L Bonetti","year":"2024","unstructured":"Bonetti L, et al. A Th17 cell-intrinsic glutathione\/mitochondrial-IL-22 axis protects against intestinal inflammation. Cell Metab. 2024;36(8):1726\u2013e174410.","journal-title":"Cell Metab"},{"issue":"9","key":"2160_CR39","doi-asserted-by":"publisher","first-page":"166171","DOI":"10.1016\/j.bbadis.2021.166171","volume":"1867","author":"Y Che","year":"2021","unstructured":"Che Y, et al. IL-22 ameliorated cardiomyocyte apoptosis in cardiac ischemia\/reperfusion injury by blocking mitochondrial membrane potential decrease, inhibiting ROS and cytochrome C. Biochim Biophys Acta Mol Basis Dis. 2021;1867(9):166171.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2160_CR40","doi-asserted-by":"crossref","unstructured":"He S, et al. Fatty acid synthesis promotes MtDNA release via ETS1-mediated oligomerization of VDAC1 facilitating endothelial dysfunction in sepsis-induced lung injury. Cell Death Differ; 2025.","DOI":"10.1038\/s41418-025-01524-5"},{"issue":"6","key":"2160_CR41","doi-asserted-by":"publisher","first-page":"e1627","DOI":"10.1002\/wsbm.1627","volume":"15","author":"LA Garrett-Sinha","year":"2023","unstructured":"Garrett-Sinha LA. An update on the roles of transcription factor Ets1 in autoimmune diseases. WIREs Mech Dis. 2023;15(6):e1627.","journal-title":"WIREs Mech Dis"},{"issue":"4","key":"2160_CR42","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00408-023-00639-1","volume":"201","author":"M Yang","year":"2023","unstructured":"Yang M, et al. ETS1 ameliorates Hyperoxia-Induced bronchopulmonary dysplasia in mice by activating Nrf2\/HO-1 mediated ferroptosis. Lung. 2023;201(4):425\u201341.","journal-title":"Lung"},{"issue":"7","key":"2160_CR43","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41419-022-05022-1","volume":"13","author":"K Vishnoi","year":"2022","unstructured":"Vishnoi K, et al. Ets1 mediates Sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma. Cell Death Dis. 2022;13(7):581.","journal-title":"Cell Death Dis"},{"issue":"12","key":"2160_CR44","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/rheumatology\/ket315","volume":"52","author":"M Carri\u00f3n","year":"2013","unstructured":"Carri\u00f3n M, et al. IL-22\/IL-22R1 axis and S100A8\/A9 alarmins in human Osteoarthritic and rheumatoid arthritis synovial fibroblasts. Rheumatology (Oxford). 2013;52(12):2177\u201386.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"2160_CR45","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/labinvest.2009.147","volume":"90","author":"A Sekikawa","year":"2010","unstructured":"Sekikawa A, et al. Involvement of the IL-22\/REG ialpha axis in ulcerative colitis. Lab Invest. 2010;90(3):496\u2013505.","journal-title":"Lab Invest"},{"key":"2160_CR46","doi-asserted-by":"publisher","first-page":"1169232","DOI":"10.3389\/fimmu.2023.1169232","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang J, Yin T, Liu S. Dysregulation of immune response in PCOS organ system. Front Immunol. 2023;14:1169232.","journal-title":"Front Immunol"},{"key":"2160_CR47","doi-asserted-by":"crossref","unstructured":"Rudnicka E, et al. Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci. 2021;22(7):3789.","DOI":"10.3390\/ijms22073789"},{"issue":"1","key":"2160_CR48","doi-asserted-by":"publisher","first-page":"22771","DOI":"10.1038\/s41598-025-05137-3","volume":"15","author":"I Raghunath","year":"2025","unstructured":"Raghunath I, et al. Effects of Piperine on intestinal permeation, pharmacodynamics and pharmacokinetics of insulin loaded Chitosan coated solid lipid nanoparticles in rats. Sci Rep. 2025;15(1):22771.","journal-title":"Sci Rep"},{"key":"2160_CR49","doi-asserted-by":"publisher","first-page":"125937","DOI":"10.1016\/j.ijpharm.2025.125937","volume":"682","author":"S Yadav","year":"2025","unstructured":"Yadav S, et al. Advances in cancer therapy: a critical review of \u03b2-cyclodextrins conjugated nanoparticle delivery systems as molecularly targeted therapies. Int J Pharm. 2025;682:125937.","journal-title":"Int J Pharm"},{"issue":"1","key":"2160_CR50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s43939-025-00317-4","volume":"5","author":"V Chandrakala","year":"2025","unstructured":"Chandrakala V, et al. Cubosomes for rheumatoid arthritis: enhancing anti-inflammatory drug delivery. Discover Mater. 2025;5(1):109.","journal-title":"Discover Mater"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02160-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02160-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02160-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:03:35Z","timestamp":1773788615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02160-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2160"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02160-y","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is not any potential or actual conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We confirmed that all animal experiments in this study were followed by the ARRIVE guidelines. This study was approved by the Animal Ethics Committee of the Hunan Provincial Maternal and Child Health Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}}],"article-number":"57"}}